Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia; Pharmacy Department, Austin Health, Heidelberg, Victoria, Australia.
Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Res Social Adm Pharm. 2020 Oct;16(10):1392-1397. doi: 10.1016/j.sapharm.2020.01.010. Epub 2020 Jan 22.
Medication-related problems and inappropriate medication use are prevalent among people attending memory clinics. There have been no deprescribing intervention studies in this setting.
To evaluate the feasibility of a pharmacist-led interdisciplinary deprescribing intervention study in a memory clinic.
A pre-post-intervention study conducted at an outpatient memory clinic of an Australian tertiary care public hospital. Participants were English-speaking, community-dwelling patients identified as being at risk of a medication-related problem, or their carers. Participants received a medication review in their home from a consultant pharmacist who collaborated with the patient/carer, memory clinic, general practitioner and community pharmacist to develop a plan for optimising medication use. The primary outcome was feasibility, based on i) proportion of memory clinic patients eligible for the study, ii) proportion of eligible patients who consented, and iii) proportion of pharmacist-identified inappropriate/unnecessary medications that were deprescribed (reduced or ceased) at six months.
One-third of memory clinic patient/carers were eligible (n = 82/238), 61% (n = 50/82) consented to participate. The median (IQR) age of participants who received the intervention (n = 46) was 80.5 (71.5-85.0) years and median (IQR) number of medications was 11 (8.0-13.3). Pharmacists recommended deprescribing 124 medications, and 53 (42.7%) had been ceased or dose-reduced at six months.
It was feasible to recruit study participants and deliver a pharmacist-led interdisciplinary deprescribing intervention in this memory clinic setting. A larger, multi-centre study with longer follow-up is needed to confirm effectiveness and clinical outcomes.
在就诊于记忆门诊的人群中,药物相关问题和不适当的药物使用较为普遍。在这种情况下,还没有进行过减少药物研究的干预研究。
评估在记忆门诊中进行药剂师主导的跨学科减少药物研究的可行性。
这是一项在澳大利亚一家三级保健公立医院的门诊记忆诊所进行的前后干预研究。参与者为讲英语、居住在社区的患者,这些患者被认为存在药物相关问题的风险,或其护理人员。参与者在家中接受顾问药剂师的药物审查,顾问药剂师与患者/护理人员、记忆诊所、全科医生和社区药剂师合作,制定优化药物使用的计划。主要结果是基于以下方面的可行性:i)有资格参加研究的记忆诊所患者的比例,ii)有资格的患者中同意参加的比例,以及 iii)药剂师确定的不适当/不必要药物在六个月内减少或停止使用的比例。
三分之一的记忆诊所患者/护理人员符合条件(n=82/238),61%(n=50/82)同意参加。接受干预的参与者(n=46)的中位(IQR)年龄为 80.5(71.5-85.0)岁,中位数(IQR)用药数为 11(8.0-13.3)。药剂师建议减少药物 124 种,其中 53 种(42.7%)已在六个月内停止或减少剂量。
在这种记忆诊所环境中,招募研究参与者并提供药剂师主导的跨学科减少药物干预是可行的。需要进行更大规模、多中心的研究,以进行更长时间的随访,从而确认有效性和临床结局。